The processes underlying of SARS-CoV-2-induced lung fibrosis are not completely understood, but imbalances of the renin–angiotensin system [54] and low levels of circulating interferon gamma [55] have been reported as potentially relevant to fibrosis following COVID-19. This evidence concerns the gene REN and pulmonary fibrosis.